Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism

Hypertension

Volumn 37, Issue 2 II, 2001, Pages 640-644

  Dubey, Raghvendra K ^a,b   Jackson, Edwin K ^b   Keller, Paul J ^a   Imthurn, Bruno ^a   Rosselli, Marinella ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cardiovascular disease; Coronary artery; Endothelial cells; Estradiol metabolites; Postmenopause; Vascular remodeling

Indexed keywords

ESTRADIOL; ESTROGEN RECEPTOR;

ANIMAL CELL; CARDIOVASCULAR DISEASE; CELL GROWTH; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ESTROGEN SYNTHESIS; HEART PROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR AFFINITY; SMOOTH MUSCLE FIBER; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0035095739     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.37.2.640     Document Type: Conference Paper

References (24)

1. Estrogen-induced cardiorenal protection: Potential cellular, biochemical and molecular mechanisms
2. Pathophysiology of endothelin in the cardiovascular system
3. Oestrogen and progesterone inhibit the stimulated production of endothelin-1
4. Estrogen attenuates ednothelin-1 production by bovine endothelial cells via estrogen receptor
5. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice
6. Estrogen inhibits the vascular injury response in estrogen receptor beta-deficient female mice
7. Sexually dimorphic response of the balloon-injured rat carotid artery to hormone treatment
8. Increased expression of estrogen receptor β mRNA in male blood vessels after vascular injury
9. Anti-proliferative effect of 2-methoxyestradiol on cultured smooth muscle cells from rabbit aorta
10. Estrogen and tamoxifen metabolites protect smooth muscle cell membrane phospholipids against peroxidation and inhibit cell growth
11. Characteristics of porcine coronary artery endothelial cells in culture: Comparison with aortic endothelium
12. Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity
13. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β
14. Methoxyestradiols mediate the antimitogenic effects of estradiol on vascular smooth muscle cells via estrogen receptor-independent mechanisms
15. 17β-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth
16. Stable over-expression of estrogen receptor-α in ECV304 cells inhibits proliferation and levels of secreted endothelin-1 and vascular endothelial growth factor
17. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells
18. Hormones and Vasoprotection
19. Concentrations of 2-methoxyestradiol in human serum measured by a heterologous immunoassay with an 1251-labelled ligand
20. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis
21. 2-Hydroxyestrogens: Chemistry, biogenesis, metabolism and physiological significance
22. Differential effects of hormone-replacement therapy on endogenous nitric oxide (nitrate/nitrite) levels in postmenopausal women substituted with 17βestradiol valerate and eyproterone acetate or medroxyprogesterone acetate
23. Circulating nitric oxide (nitrite/nitrate) levels in postmenopausal women substituted with 17β-estradiol and norethisterone acetate: A 2 year follow-up-study
24. Antioxidant protection of LDL by physiological concentrations of 17β-estradiol: Requirement for estradiol modification